Health

LGBT community has poorer health outcomes, assessment finds

The local LGBT community reports twice the number of poor mental health days as the general population of Richmond and Columbia Counties, and those who identified as transgender report twice that, according to a health needs ...

Health

Are there health benefits to taking turmeric?

Can an ancient yellow root spice be good for you? A recent study published in the Proceedings of the National Academy of Sciences shows curcumin, an active ingredient in turmeric, effectively kills certain cancer cells. While ...

Cancer

Q&A: Women 65 and older may not need Pap tests

Dear Mayo Clinic: I am way past my childbearing years and do not have any health problems. Do I need to continue getting Pap smears? At what age is this test no longer necessary?

Health

Smart pills dumb down medical care, experts warn

Enthusiasm for an emerging digital health tool, the smart pill, is on the rise but researchers at the University of Illinois at Chicago have published a paper in the American Journal of Bioethics that cautions health care ...

Alzheimer's disease & dementia

US Alzheimer's cases to nearly triple by 2060

(HealthDay)—By 2060, almost 14 million Americans will suffer from Alzheimer's disease, a number that's nearly three times as high as today, a new report projects.

Health

For-profit hospitals correlated with higher readmission rates

Patients who receive care in a for-profit hospital are more likely to be readmitted than those who receive care in nonprofit or public hospitals, according to a new study published by University of Illinois at Chicago researchers.

Cardiology

New device approved for tears in heart's blood vessels

(HealthDay)—The PK Papyrus Covered Coronary Stent System has been approved by the U.S. Food and Drug Administration to treat acute coronary artery perforations, the medical term for tears in the heart's blood vessels.

Arthritis & Rheumatism

Pharmacovigilance needed for rheumatology patients

(HealthDay)—Recommendations have been developed for pharmacovigilance in rheumatology, emphasizing the need for continued monitoring of new drugs, according to a position statement issued by the American College of Rheumatology ...

page 12 from 23